PRO B-TYPE NATRIURETIC PEPTIDE SIGNIFICANTLY PREDICTS FUTURE VASCULAR EVENTS IN PERIPHERAL ARTERIAL DISEASE PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Vonbank, A. [1 ]
Saely, C. [1 ]
Rein, P. [1 ]
Zanolin, D. [2 ]
Leiherer, A. [2 ]
Drexel, H. [1 ]
机构：
[1] Acad Teaching Hosp Feldkirch, Med & Cardiol, Feldkirch, Austria
[2] Vivit Inst, Vasc Res, Feldkirch, Austria
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0131
引用
收藏
页码：E3 / E4
页数：2
相关论文
共 50 条
  • [21] Aortic Augmentation Index is Independently Associated With N-Terminal Pro B-type Natriuretic Peptide in Patients With Peripheral Arterial Disease
    Shahin, Yousef
    Chetter, Ian
    VASCULAR AND ENDOVASCULAR SURGERY, 2012, 46 (08) : 648 - 653
  • [22] Pro-B-Type Natriuretic Peptide Strongly Predicts Major Cardiovascular Events and Mortality in Cardiovascular Disease Patients with Type 2 Diabetes as Well as in Those without Diabetes
    Maechler, Maximilian
    Sprenger, Lukas
    Mader, Arthur
    Larcher, Barbara
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2022, 71
  • [23] Pro-B-type natriuretic peptide strongly predicts cardiovascular mortality in coronary artery disease patients with type 2 diabetes
    Zanolin, D.
    Rein, P.
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Leiherer, A.
    Schuler, A.
    Schwerzler, P.
    Mader, A.
    Muendlein, A.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1127 - 1127
  • [24] Pro-B-type Natriuretic Peptide Strongly Predicts Cardiovascular Mortality in Coronary Artery Disease Patients with Type 2 Diabetes
    Zanolin, Daniela
    Rein, Philipp
    Saely, Christoph H.
    Vonbank, Alexander
    Lins, Christina
    Leiherer, Andreas
    Schuler, Alexander
    Ebner, Karl-Martin
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2017, 66 : A404 - A404
  • [25] Pro-B-type natriuretic peptide strongly predicts cardiovascular mortality in coronary artery disease patients with type 2 diabetes
    Zanolin, D.
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Leiherer, A.
    Mader, A.
    Larcher, B.
    Muendlein, A.
    Drexel, H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 : 154 - 154
  • [26] Pro-B-type natriuretic peptide strongly predicts cardiovascular mortality in coronary artery disease patients with type 2 diabetes
    Zanolin, D.
    Rein, P.
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Leiherer, A.
    Schuler, A.
    Schwerzler, P.
    Mader, A.
    Muendlein, A.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S59 - S60
  • [27] B-type natriuretic peptide and risk of type 2 diabetes mellitus
    杨敏
    China Medical Abstracts (Internal Medicine), 2016, 33 (02) : 19 - 19
  • [28] PRO-B-TYPE NATRIURETIC PEPTIDE STRONGLY PREDICTS MAJOR CARDIOVASCULAR EVENTS AND MORTALITY IN CARDIOVASCULAR DISEASE PATIENTS WITH TYPE 2 DIABETES AS WELL AS IN THOSE WITHOUT DIABETES
    Maechler, M.
    Sprenger, L.
    Mader, A.
    Larcher, B.
    Vonbank, A.
    Plattner, T.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C.
    ATHEROSCLEROSIS, 2023, 379 : S188 - S188
  • [29] B-type natriuretic peptide and the risk of developing type 2 diabetes
    Yang, Min
    Ni, Changlin
    Chang, Baocheng
    Tang, Yunzhao
    Zhu, Yanjuan
    Li, Chenguang
    Jiang, Zhenhuan
    Yu, Ping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 1 - 2
  • [30] Differences of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide levels in patients with cardiogenic shock
    Buerke, Michael
    Prondzinsky, Roland
    Geppert, Alexander
    Jaral, Rudolf
    Huber, Kurt
    Russ, Martin
    Lemm, Henning
    Schlitt, Axel
    Werdan, Karl
    CIRCULATION, 2007, 116 (16) : 944 - 944
12345